Maria Krotewicz

Maria Krotewicz

Auto-generated profile, based on publicly available information

Maria Krotewicz

Breast Cancer and Reconstructive Surgery Clinic, Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2011 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
BZBarbara Ziemba
Barbara Ziemba
AJAnna Janaszewska
Anna Janaszewska
Karol CiepluchKarol Ciepluch
Karol Ciepluch
MKMaria Krotewicz
Maria Krotewicz
WFWiesława A. Fogel
Wiesława A. Fogel
BKBarbara Klajnert-Maculewicz
Barbara Klajnert-Maculewicz

1 April 2001 in Behavioural Brain Research
Verified
Journal Article
Closed access
ARAndrzej Romaniuk
Andrzej Romaniuk
MKMilena Koprowska
Milena Koprowska
MKMaria Krotewicz
Maria Krotewicz
MSMagdalena Strzelczuk
Magdalena Strzelczuk
MWMAREK WIECZOREK
MAREK WIECZOREK

31 March 1999 in Acta Neurobiologiae Experimentalis
Verified
Journal Article
Open access
PDF file
MKMilena Koprowska
Milena Koprowska
MKMaria Krotewicz
Maria Krotewicz
ARAndrzej Romaniuk
Andrzej Romaniuk
MSMagdalena Strzelczuk
Magdalena Strzelczuk
MWMAREK WIECZOREK
MAREK WIECZOREK
The aim of the present study is to examine the effects of serotonin synthesis inhibition with p-Chlorophenylalanine (p-CPA) in rats on (1) anxiety behavior examined in the light-dark crossing test and, (2) regional brain concentration of monoamines (NA, DA and 5-HT) and their metabolites (MHPG, DOPAC, HVA and 5-HIAA) as well as GABA in the hypothalamus, amygdala, hippocampus, midbrain central gray matter and the frontal cortex. Treatment of animals with p-CP A produced a significant increase in time out from the illuminated part of the chamber and in time of locomotor activity in the illuminated part of the chamber. HPLC analysis showed a significant reduction of 5-HT and 5-HIAA concentration in all examined brain regions with the exception of the frontal cortex. Additionally, a significant decrease in DA and its metabolites, DOPAC and HVA occurred in the hypothalamus and amygdala. Moreover, we observed a significant decrease in frontal cortex NA concentration after p-CPA administration. The results of our study suggest that administration of p-CPA is effective in reduction of anxiety through depletion of 5-HT accompanied by diminution of catecholamines, especially DA and its metabolites in the main emotional brain regions.

30 June 2004 in Acta Neurobiologiae Experimentalis
Verified
Journal Article
Open access
PDF file
MKMilena Koprowska
Milena Koprowska
MKMaria Krotewicz
Maria Krotewicz
ARAndrzej Romaniuk
Andrzej Romaniuk
MSMagdalena Strzelczuk
Magdalena Strzelczuk
Differences in fear level assessment based on the time of motionless in the illuminated compartment, time spent in light compartment, number of head dipping from dark to the illuminated compartment and number of returns from dark to the illuminated compartment registered in light/dark transitions test and brain monoamines (NA, DA, 5-HT) and their metabolites (MHPG, DOPAC, 5-HIAA) in the hypothalamus, midbrain, amygdala, hippocampus and pons were examined in 3, 12 and 24 months old Wistar rats. The lowest level of fear was registered in 12 months old rats, a slightly higher level in 3 months old rats and the highest in 24 months old rats. Locomotion activity showed a decreasing tendency within age according to a linear dependence in 3, 12 and 24 months old rats. Neurochemical data showed the decreased activity of NA system and increased activity of DA system in most structures already occurred in 12 months old rats. It remained at the same level in aged rats. The correlation analysis between the behavioral markers of fear level and distribution of monoamines in young, mature and aged rats showed diversified data, only some of them being consistent with the "serotonergic hypothesis" of fear/anxiety. Therefore, we cannot conclude what neurochemical background of fear is.

18 March 2021 in EJNMMI Research
Verified
Journal Article
Open access
PDF file
PJPatriek A. G. T. Jurrius
Patriek A. G. T. Jurrius
MGMaarten R. Grootendorst
Maarten R. Grootendorst
MKMarika Krotewicz
Marika Krotewicz
MCMassimiliano Cariati
Massimiliano Cariati
AKAshutosh Kothari
Ashutosh Kothari
MTMaria Turska-D’aMico
Maria Turska-D’aMico
Introduction: In women undergoing breast-conserving surgery (BCS), 20–25% require a re-operation as a result of incomplete tumour resection. An intra-operative technique to assess tumour margins accurately would be a major advantage. A novel method for intraoperative margin assessment was developed by applying a thin flexible scintillating film to specimens—flexible autoradiography (FAR) imaging. A single-arm, multi-centre study was conducted to evaluate the feasibility of intraoperative [18F]FDG FAR for the assessment of tumour margins in BCS. Methods: Eighty-eight patients with invasive breast cancer undergoing BCS received ≤ 300 MBq of [18F]FDG 60–180 min pre-operatively. Following surgical excision, intraoperative FAR imaging was performed using the LightPath® Imaging System. The first 16 patients were familiarisation patients; the remaining 72 patients were entered into the main study. FAR images were analysed post-operatively by three independent readers. Areas of increased signal intensity were marked, mean normalised radiances and tumour-to-tissue background (TBR) determined, agreement between histopathological margin status and FAR assessed and radiation dose to operating theatre staff measured. Subgroup analyses were performed for various covariates, with thresholds set based on ROC curves. Results: Data analysis was performed on 66 patients. Intraoperative margin assessment using FAR was completed on 385 margins with 46.2% sensitivity, 81.7% specificity, 8.1% PPV, 97.7% NPV and an overall accuracy of 80.5%, detecting both invasive carcinoma and DCIS. A subgroup analysis based on [18F]FDG activity present at time of imaging revealed an increased sensitivity (71.4%), PPV (9.3%) and NPV (98.4%) in the high-activity cohort with mean tumour radiance and TBR of 126.7 ± 45.7 photons/s/cm2/sr/MBq and 2.1 ± 0.5, respectively. Staff radiation exposure was low (38.2 ± 38.1 µSv). Conclusion: [18F]FDG FAR is a feasible and safe technique for intraoperative tumour margin assessment. Further improvements in diagnostic performance require optimising the method for scintillator positioning and/or the use of targeted radiopharmaceuticals. Trial registration: Identifier: NCT02666079. Date of registration: 28 January 2016. URL: https://clinicaltrials.gov/ct2/show/NCT02666079. ISRCTN registry: Reference: ISRCTN17778965. Date of registration: 11 February 2016. URL: http://www.isrctn.com/ISRCTN17778965.

30 June 2002 in Acta Neurobiologiae Experimentalis
Verified
Journal Article
Open access
PDF file
KMKoprowska M.
Koprowska M.
KMKrotewicz M.
Krotewicz M.
RARomaniuk A.
Romaniuk A.
SMStrzelczuk M.
Strzelczuk M.
MWMAREK WIECZOREK
MAREK WIECZOREK
The effects of8-0HDPAT and UH-30l injection into the dorsal raphe nucleus (DRN) on fear behavior of the light-dark transitions test and regional brain monoamines (NA, DA, 5-HT) and their metabolites (MHPG, DOPAC, 5-HIAA) in the hypothalamus (HPT), midbrain central gray matter (MID), amygdala (AMY), hippocampus (HIP) and pons (PO) were examined. An injection of8-0HDPAT (300 ng) as well UH-30l (300 ng) into the DRN evoked an increase in the number of head dipping from dark to the illuminated compartment of chamber, an increase of time of motionless in the dark compartment and decrease of time of locomotion activity in the illuminated compartment. HPLC analysis showed reduction of 5-HIAA/5-HT ratio in the HPT, HIP and PO, increase of MHPG/NA ratio in the HIP and PO, and increase of DA content in the HPT, AMY and HIP after 8-OHDPAT injection. But injection ofUH-30l reduced 5-HT in the MID and increased in the AMY, reduced 5-HIAA content in the HIP and increased in the MID and decreased MHPG/NA ratio in the PO. These results indicate that both 5-HT1A receptor agonists, acting on the 5HT1A autoreceptors caused the anxiolytic effects, reduced fear behavior on the rat connected with infringement of dynamic balance between the serotonergic and catecholaminergics systems.